Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
AUTOR(ES)
Bourbeau, Jean
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117108Documentos Relacionados
- Reducing inflammation in COPD: the evidence builds
- Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
- Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
- Inhaled corticosteroids in COPD: awaiting controlled trials.
- Randomised controlled trial of effect of feedback on general practitioners’ prescribing in Australia